Estradiol
- All
- News
-
Researchers Identify An Enzyme As The Cause Of Depression
According to the study, women are roughly twice as likely as males to experience depression. Women who have lost estradiol may experience depressive symptoms.
-
Why Are Some Women More Prone To Depression
Fluctuations in hormones due to the menstrual cycle and or an earlier menopause makes women more prone to the risk of depression, according to a new study.
-
Lupin Gets Final Nod From USFDA For Birth Control Pill
Lupin has received final approval from the US health regulator for marketing Norgestimate and Ethinyl Estradiol tablets in the US market.
-
Lupin Launches Generic Oral Contraceptive Tablets In US
Drug firm Lupin has launched its generic oral contraceptive Norgestimate and ethinyl estradiol tablets in the American market after receiving nod from the US health regulator.
-
Lupin Launches Osteoporosis Drug in US
Drug firm Lupin has launched its generic norethindrone acetate and ethinyl estradiol tablets used for the prevention of postmenopausal osteoporosis in the US market.
-
Glenmark Pharma Gets USFDA Nod For Two Generic Drugs
Glenmark Pharma today said it has received final approval from the USFDA to manufacture and market Potassium Chloride extended release capsules and oral contraceptive Norethindrone Acetate and Ethinyl Estradiol tablets in the American market.
-
Ingredient in Shampoos, Sunscreens May Up Breast Cancer Risk
Parabens - common chemicals found in personal care products such as shampoos, body lotions and sunscreens - may increase breast cancer risk even at low doses, according to a new study.
-
Glenmark Gets US Regulator's Nod for Contraceptive Tablets
Glenmark Pharmaceuticals has received final nod from the US Food and Drug Administration for generic oral contraceptive Levonorgestrel/Ethinyl Estradiol tablets and plans to commence shipping of the product immediately.
-
Favourable ruling for generic Yaz in US court, says Lupin
A US court has ruled in Lupins favour paving the way for the company to introduce a generic version of Bayer AGs Yaz tablets in the American market, the drug major said in a statement on Wednesday.
-
Glenmark gets nod from US health regulator for oral contraceptive pills
Drug firm Glenmark Pharmaceuticals said it has received final approval from the US health regulator for its generic contraceptive norgestimate and ethinyl estradiol tablets.
-
Glenmark Pharmaceuticals Ltd - Glenmark Generics receives USFDA approval for Norgestimate and Ethinyl Estradiol tablets
Glenmark Generics Inc., USA, a subsidiary of Glenmarlc Generics Ltd, today announced they, have been granted final approval for’ their abbreviated new drug application (ANDA) by the United States Food and Drug Administration (U.S. FDA) for Norgestimate and Ethinyl Estradio1 tablets, USP 0.18 mg /O.035 mg, 0.215 mg/0.035 mg and 0.25/0.035 mg. Gle...
-
Glenmark Pharmaceuticals Ltd - Glenmark Generics receives final approval from USFDA for Norethindrone and Ethinyl Estradiol, USP 0.4 mg/0.035 mg table
The board at its meeting held on October 29, 2011 has approved for the same
-
Researchers Identify An Enzyme As The Cause Of Depression
According to the study, women are roughly twice as likely as males to experience depression. Women who have lost estradiol may experience depressive symptoms.
-
Why Are Some Women More Prone To Depression
Fluctuations in hormones due to the menstrual cycle and or an earlier menopause makes women more prone to the risk of depression, according to a new study.
-
Lupin Gets Final Nod From USFDA For Birth Control Pill
Lupin has received final approval from the US health regulator for marketing Norgestimate and Ethinyl Estradiol tablets in the US market.
-
Lupin Launches Generic Oral Contraceptive Tablets In US
Drug firm Lupin has launched its generic oral contraceptive Norgestimate and ethinyl estradiol tablets in the American market after receiving nod from the US health regulator.
-
Lupin Launches Osteoporosis Drug in US
Drug firm Lupin has launched its generic norethindrone acetate and ethinyl estradiol tablets used for the prevention of postmenopausal osteoporosis in the US market.
-
Glenmark Pharma Gets USFDA Nod For Two Generic Drugs
Glenmark Pharma today said it has received final approval from the USFDA to manufacture and market Potassium Chloride extended release capsules and oral contraceptive Norethindrone Acetate and Ethinyl Estradiol tablets in the American market.
-
Ingredient in Shampoos, Sunscreens May Up Breast Cancer Risk
Parabens - common chemicals found in personal care products such as shampoos, body lotions and sunscreens - may increase breast cancer risk even at low doses, according to a new study.
-
Glenmark Gets US Regulator's Nod for Contraceptive Tablets
Glenmark Pharmaceuticals has received final nod from the US Food and Drug Administration for generic oral contraceptive Levonorgestrel/Ethinyl Estradiol tablets and plans to commence shipping of the product immediately.
-
Favourable ruling for generic Yaz in US court, says Lupin
A US court has ruled in Lupins favour paving the way for the company to introduce a generic version of Bayer AGs Yaz tablets in the American market, the drug major said in a statement on Wednesday.
-
Glenmark gets nod from US health regulator for oral contraceptive pills
Drug firm Glenmark Pharmaceuticals said it has received final approval from the US health regulator for its generic contraceptive norgestimate and ethinyl estradiol tablets.
-
Glenmark Pharmaceuticals Ltd - Glenmark Generics receives USFDA approval for Norgestimate and Ethinyl Estradiol tablets
Glenmark Generics Inc., USA, a subsidiary of Glenmarlc Generics Ltd, today announced they, have been granted final approval for’ their abbreviated new drug application (ANDA) by the United States Food and Drug Administration (U.S. FDA) for Norgestimate and Ethinyl Estradio1 tablets, USP 0.18 mg /O.035 mg, 0.215 mg/0.035 mg and 0.25/0.035 mg. Gle...
-
Glenmark Pharmaceuticals Ltd - Glenmark Generics receives final approval from USFDA for Norethindrone and Ethinyl Estradiol, USP 0.4 mg/0.035 mg table
The board at its meeting held on October 29, 2011 has approved for the same
